Dublin, Ireland – January 10, 2014 – Shire plc (LSE: SHP, NASDAQ: SHPG) announces that it has extended the expiration of its previously announced tender offer by a wholly owned subsidiary of Shire for all of the outstanding common shares of ViroPharma Incorporated (NASDAQ: VPHM) until midnight, New York City time, on Thursday, January 23, 2014 […]
Patients with ulcerative colitis (UC) can find information, tips and tools to help manage their disease at www.ShireUCentral.com Chesterbrook, PA, US – December 12, 2013 – Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, is pleased to announce the launch ofwww.ShireUCentral.com, an online disease information and resource center for US patients with ulcerative colitis. UC is […]
Philadelphia, PA, United States – December 2, 2013 – Shire plc (LSE: SHP, NASDAQ: SHPG), announces that its subsidiary Shire US Inc. has entered into an agreement to supply an authorized generic version of its product Adderall XR. Under the agreement, Sandoz Inc. will market an authorized generic version of Adderall XR® beginning July 1, 2016. […]